ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,367Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 427

$889K Total Retail Price of All Prescriptions

Rank: 8 out of 427

535 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

20% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 16,976 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $107 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 909 869 1 7
LEVOTHYROXINE SODIUM 810 746 2 4
LISINOPRIL 753 721 3 2
OMEPRAZOLE 704 671 4 1
METOPROLOL TARTRATE 624 610 5 8
DONEPEZIL HCL 535 531 6 25
HYDROCODONE-ACETAMINOPHEN 476 436 S3 7 6
MIRTAZAPINE 349 337 8 42
AMLODIPINE BESYLATE 344 328 9 5
METOPROLOL SUCCINATE 341 305 10 10
METFORMIN HCL 337 290 11 11
JANTOVEN 274 254 12 92
GABAPENTIN 271 224 13 14
SIMVASTATIN 252 219 14 3
PAROXETINE HCL 244 220 15 68
GLYBURIDE 233 195 R 16 112
CITALOPRAM HBR 225 201 17 19
POTASSIUM CHLORIDE 223 222 18 45
CLONIDINE HCL 222 210 19 103
DIOVAN 218 218 20 34
ISOSORBIDE MONONITRATE ER 203 200 21 47
SPIRONOLACTONE 201 193 22 46
NAMENDA 199 198 23 57
ATORVASTATIN CALCIUM 192 154 24 12
ALENDRONATE SODIUM 189 161 25 23
CARVEDILOL 187 187 26 17
TRAZODONE HCL 183 162 27 35
LOVASTATIN 180 178 28 60
METHADONE HCL 172 160 S2 29 66
CLOPIDOGREL 164 158 30 33
CYMBALTA 163 137 31 52
ATENOLOL 145 145 32 15
RANITIDINE HCL 133 121 33 27
VITAMIN D2 129 129 34 161
SERTRALINE HCL 125 114 35 22
PLAVIX 122 116 36 67
ADVAIR DISKUS 121 121 37 37
ZOLPIDEM TARTRATE 121 99 37 21
LACTULOSE 116 97 39 108
SPIRIVA 116 116 39 40
CARBIDOPA-LEVODOPA 116 116 39 88
HYDRALAZINE HCL 106 106 42 97
OXYBUTYNIN CHLORIDE 104 84 43 199
DIVALPROEX SODIUM 101 96 44 70
PANTOPRAZOLE SODIUM 98 81 45 39
DILTIAZEM 24HR CD 92 85 46 207
EXELON 90 90 47 128
TAMSULOSIN HCL 89 88 48 48
GLIPIZIDE 86 86 49 139
TRAMADOL HCL 86 85 49 32
CELEBREX 85 85 51 176
ENALAPRIL MALEATE 82 82 52 80
POLYETHYLENE GLYCOL 3350 82 80 52 44
ALLOPURINOL 79 68 54 127
NYSTATIN 78 72 55 104
COLCRYS 75 75 56 277
WARFARIN SODIUM 74 70 57 9
DIGOXIN 73 73 58 53
FAMOTIDINE 72 35 59 64
LANTUS 70 45 60 120
LEVETIRACETAM 70 62 60 41
RISPERIDONE 70 61 60 29
DILTIAZEM 24HR ER 67 61 63 115
QUINAPRIL HCL 66 66 64 173
PROAIR HFA 65 54 65 56
DILTIAZEM HCL 65 64 65 296
FINASTERIDE 64 61 67 93
HYDROCORTISONE 64 60 67 235
QUETIAPINE FUMARATE 64 60 67 51
METOLAZONE 62 62 70 224
CRESTOR 60 57 71 16
AZITHROMYCIN 59 56 72 55
PHENYTOIN SODIUM EXTENDED 57 57 73 214
VESICARE 57 57 73 184
LIDODERM 56 52 75 164
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 51 76 38
INSULIN SYRINGE 54 38 77 157
MELOXICAM 54 42 77 58
PREDNISONE 52 51 79 26
NASONEX 51 51 80 347
RIVASTIGMINE 51 39 80 207
DETROL LA 50 49 82 354
LIPITOR 50 40 82 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.